EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 31 / No 6-7 (Juin–Juillet 2015) Med Sci (Paris), 31 6-7 (2015) 597-600 References
Free Access
Issue
Med Sci (Paris)
Volume 31, Number 6-7, Juin–Juillet 2015
Page(s) 597 - 600
Section Nouvelles
DOI https://doi.org/10.1051/medsci/20153106008
Published online 07 July 2015
  1. Knowles TP, Vendruscolo M, Dobson CM. The amyloid state and its association with protein misfolding diseases. Nat Rev Mol Cell Biol 2014 ; 15 : 384–396. [CrossRef] [PubMed] [Google Scholar]
  2. Spillantini MG, Schmidt ML, Lee VM, et al. Alpha-synuclein in Lewy bodies. Nature 1997 ; 388 : 839–840. [CrossRef] [PubMed] [Google Scholar]
  3. Bellucci A, Zaltieri M, Navarria L, et al. From alpha-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson’s disease. Brain Res 2012 ; 1476 : 183–202. [CrossRef] [PubMed] [Google Scholar]
  4. Fink AL. The aggregation and fibrillation of alpha-synuclein. Acc Chem Res 2006 ; 39 : 628–634. [CrossRef] [PubMed] [Google Scholar]
  5. Grey M, Dunning CJ, Gaspar R, et al. Acceleration of alpha-synuclein aggregation by exosomes. J Biol Chem 2015 ; 290 : 2969–2982. [CrossRef] [PubMed] [Google Scholar]
  6. Hellstrand E, Nowacka A, Topgaard D, et al. Membrane lipid co-aggregation with alpha-synuclein fibrils. PLoS One 2013 ; 8 : e77235. [CrossRef] [PubMed] [Google Scholar]
  7. Cohen SI, Linse S, Luheshi LM, et al. Proliferation of amyloid-beta42 aggregates occurs through a secondary nucleation mechanism. Proc Natl Acad Sci USA 2013 ; 110 : 9758–9763. [CrossRef] [Google Scholar]
  8. Cohen SI, Arosio P, Presto J, et al. A molecular chaperone breaks the catalytic cycle that generates toxic Abeta oligomers. Nat Struct Mol Biol 2015 ; 22 : 207–213. [CrossRef] [PubMed] [Google Scholar]
  9. Galvagnion C, Buell AK, Meisl G, et al. Lipid vesicles trigger alpha-synuclein aggregation by stimulating primary nucleation. Nat Chem Biol 2015 ; 11 : 229–234. [CrossRef] [PubMed] [Google Scholar]
  10. Buell AK, Galvagnion C, Gaspar R, et al. Solution conditions determine the relative importance of nucleation and growth processes in alpha-synuclein aggregation. Proc Natl Acad Sci USA 2014 ; 111 : 7671–7676. [CrossRef] [Google Scholar]
  11. Campioni S, Carret G, Jordens S, et al. The presence of an air-water interface affects formation and elongation of alpha-synuclein fibrils. J Am Chem Soc 2014 ; 136 : 2866–2875. [CrossRef] [PubMed] [Google Scholar]
  12. Braak H, Del Tredici K, Rub U, et al. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 2003 ; 24 : 197–211. [Google Scholar]
  13. Brundin P, Li JY, Holton JL, et al. Research in motion: the enigma of Parkinson’s disease pathology spread. Nat Rev Neurosci 2008 ; 9 : 741–745. [CrossRef] [PubMed] [Google Scholar]
  14. Gruenberg J. The endocytic pathway: a mosaic of domains. Nat Rev Mol Cell Biol 2001 ; 2 : 721–730. [CrossRef] [PubMed] [Google Scholar]
  15. Corti O, Brice A. La maladie de Parkinson : que nous apprennent les gènes responsables des formes familiales ? Med Sci (Paris) 2003 ; 19 : 613–619. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  16. Cohen SI, Vendruscolo M, Dobson CM, et al. From macroscopic measurements to microscopic mechanisms of protein aggregation. J Mol Biol 2012 ; 421 : 160–171. [Google Scholar]
  17. Singleton AB, Farrer M, Johnson J, et al. alphasynuclein locus triplication causes Parkinson’s disease. Science 2003 ; 302 : 841. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.